Natural compounds may open new routes to treatment of amyloid diseases
about
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's diseaseThe potential of chitosan and its derivatives in prevention and treatment of age-related diseases.Flavone derivatives as inhibitors of insulin amyloid-like fibril formation.An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation.FBS or BSA Inhibits EGCG Induced Cell Death through Covalent Binding and the Reduction of Intracellular ROS Production.Protein misfolding in neurodegenerative diseases: implications and strategies.Epigenetic drug discovery for Alzheimer's disease.Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form.Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their MetabolitesLooking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives.The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios.LED-based interferometric reflectance imaging sensor for the detection of amyloid-β aggregation.Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.Organoruthenium(II) Complexes Ameliorates Oxidative Stress and Impedes the Age Associated Deterioration in Caenorhabditis elegans through JNK-1/DAF-16 Signalling.
P2860
Q28468287-0F2631A5-D254-4958-B333-64FA7BC0E639Q35548877-2F78979B-F832-4BB5-9BFA-B55C47E0676BQ35584160-055546BC-7D9C-4F39-AAEA-8118173C371BQ36593553-117DC02E-2732-4F89-911A-D861242E881DQ37251550-2069398E-C5E9-4A3A-B0CD-ED4C54B327B7Q37382676-A10BF5AE-CF10-4A86-AF54-D018B14F26B1Q37697832-958E0B84-376D-45C4-9194-A880EDC01007Q38225708-A2840A20-5408-443D-ADDC-D9D96965506DQ40284291-029A289E-8E73-4587-9509-88D2A3F7C48BQ40430478-919E4800-C790-43AC-B864-D2C294AF250DQ40484092-F34A16ED-8E58-45F3-ACA4-B0D52F2805F1Q41892980-37889C7B-0FA2-42D1-B6BF-1B9F97777A5CQ43470859-9E32C271-E3A5-4587-9B4B-B7497580379FQ47136102-0E3A5918-0153-46D7-97E2-8F962D4D5CDCQ48215239-590A349A-DEA2-41D2-BCEA-4380793293C7Q49374917-ED69A297-3F05-496B-A911-4CD2E64C9989Q55026709-E86FA47F-159C-45B3-8AA2-0C946C8FEF1C
P2860
Natural compounds may open new routes to treatment of amyloid diseases
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Natural compounds may open new routes to treatment of amyloid diseases
@en
type
label
Natural compounds may open new routes to treatment of amyloid diseases
@en
prefLabel
Natural compounds may open new routes to treatment of amyloid diseases
@en
P2860
P1433
P1476
Natural compounds may open new routes to treatment of amyloid diseases
@en
P2093
Jan Bieschke
P2860
P2888
P304
P356
10.1007/S13311-013-0192-7
P577
2013-07-01T00:00:00Z